FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4367693876> ?p ?o ?g. }

• W4367693876 endingPage "287" @default.
• W4367693876 startingPage "272" @default.
• W4367693876 abstract "We hypothesized that implementation facilitation would enable us to rapidly and effectively implement emergency department (ED)-initiated buprenorphine programs in rural and urban settings with high-need, limited resources and dissimilar staffing structures.This multicenter implementation study employed implementation facilitation using a participatory action research approach to develop, introduce, and refine site-specific clinical protocols for ED-initiated buprenorphine and referral in 3 EDs not previously initiating buprenorphine. We assessed feasibility, acceptability, and effectiveness by triangulating mixed-methods formative evaluation data (focus groups/interviews and pre/post surveys involving staff, patients, and stakeholders), patients' medical records, and 30-day outcomes from a purposive sample of 40 buprenorphine-receiving patient-participants who met research eligibility criteria (English-speaking, medically stable, locator information, nonprisoners). We estimated the primary implementation outcome (proportion receiving ED-initiated buprenorphine among candidates) and the main secondary outcome (30-day treatment engagement) using Bayesian methods.Within 3 months of initiating the implementation facilitation activities, each site implemented buprenorphine programs. During the 6-month programmatic evaluation, there were 134 ED-buprenorphine candidates among 2,522 encounters involving opioid use. A total of 52 (41.6%) practitioners initiated buprenorphine administration to 112 (85.1%; 95% confidence interval [CI] 79.7% to 90.4%) unique patients. Among 40 enrolled patient-participants, 49.0% (35.6% to 62.5%) were engaged in addiction treatment 30 days later (confirmed); 26 (68.4%) reported attending one or more treatment visits; there was a 4-fold decrease in self-reported overdose events (odds ratio [OR] 4.03; 95% CI 1.27 to 12.75). The ED clinician readiness increased by a median of 5.02 (95% CI: 3.56 to 6.47) from 1.92/10 to 6.95/10 (n(pre)=80, n(post)=83).The implementation facilitation enabled us to effectively implement ED-based buprenorphine programs across heterogeneous ED settings rapidly, which was associated with promising implementation and exploratory patient-level outcomes." @default.
• W4367693876 created "2023-05-03" @default.
• W4367693876 creator A5001033111 @default.
• W4367693876 creator A5007112969 @default.
• W4367693876 creator A5009188249 @default.
• W4367693876 creator A5023564472 @default.
• W4367693876 creator A5025601376 @default.
• W4367693876 creator A5046216738 @default.
• W4367693876 creator A5050421558 @default.
• W4367693876 creator A5053244935 @default.
• W4367693876 creator A5062905871 @default.
• W4367693876 creator A5068525042 @default.
• W4367693876 creator A5070417720 @default.
• W4367693876 creator A5071920736 @default.
• W4367693876 creator A5076431340 @default.
• W4367693876 creator A5079051079 @default.
• W4367693876 creator A5080954307 @default.
• W4367693876 creator A5081922663 @default.
• W4367693876 creator A5089723266 @default.
• W4367693876 creator A5091086764 @default.
• W4367693876 date "2023-09-01" @default.
• W4367693876 modified "2023-10-18" @default.
• W4367693876 title "Implementing Programs to Initiate Buprenorphine for Opioid Use Disorder Treatment in High-Need, Low-Resource Emergency Departments: A Nonrandomized Controlled Trial" @default.
• W4367693876 cites W2012991178 @default.
• W4367693876 cites W2014529895 @default.
• W4367693876 cites W2021737457 @default.
• W4367693876 cites W2071453859 @default.
• W4367693876 cites W2115610172 @default.
• W4367693876 cites W2132322340 @default.
• W4367693876 cites W2132974770 @default.
• W4367693876 cites W2142149055 @default.
• W4367693876 cites W2157470053 @default.
• W4367693876 cites W2158292788 @default.
• W4367693876 cites W2163889626 @default.
• W4367693876 cites W2235825992 @default.
• W4367693876 cites W2401653577 @default.
• W4367693876 cites W2473786944 @default.
• W4367693876 cites W2546109899 @default.
• W4367693876 cites W2592673947 @default.
• W4367693876 cites W2608446001 @default.
• W4367693876 cites W2746744089 @default.
• W4367693876 cites W2808907017 @default.
• W4367693876 cites W2808979848 @default.
• W4367693876 cites W2906102371 @default.
• W4367693876 cites W2942635088 @default.
• W4367693876 cites W2946056695 @default.
• W4367693876 cites W2947435448 @default.
• W4367693876 cites W2985396839 @default.
• W4367693876 cites W3013263869 @default.
• W4367693876 cites W3013565570 @default.
• W4367693876 cites W3020830501 @default.
• W4367693876 cites W3032766253 @default.
• W4367693876 cites W3092210655 @default.
• W4367693876 cites W3092700547 @default.
• W4367693876 cites W3138839631 @default.
• W4367693876 cites W3139286676 @default.
• W4367693876 cites W3169007053 @default.
• W4367693876 cites W3176525203 @default.
• W4367693876 cites W3176959550 @default.
• W4367693876 cites W4206903838 @default.
• W4367693876 cites W4245487921 @default.
• W4367693876 doi "https://doi.org/10.1016/j.annemergmed.2023.02.013" @default.
• W4367693876 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/37140493" @default.
• W4367693876 hasPublicationYear "2023" @default.
• W4367693876 type Work @default.
• W4367693876 citedByCount "0" @default.
• W4367693876 crossrefType "journal-article" @default.
• W4367693876 hasAuthorship W4367693876A5001033111 @default.
• W4367693876 hasAuthorship W4367693876A5007112969 @default.
• W4367693876 hasAuthorship W4367693876A5009188249 @default.
• W4367693876 hasAuthorship W4367693876A5023564472 @default.
• W4367693876 hasAuthorship W4367693876A5025601376 @default.
• W4367693876 hasAuthorship W4367693876A5046216738 @default.
• W4367693876 hasAuthorship W4367693876A5050421558 @default.
• W4367693876 hasAuthorship W4367693876A5053244935 @default.
• W4367693876 hasAuthorship W4367693876A5062905871 @default.
• W4367693876 hasAuthorship W4367693876A5068525042 @default.
• W4367693876 hasAuthorship W4367693876A5070417720 @default.
• W4367693876 hasAuthorship W4367693876A5071920736 @default.
• W4367693876 hasAuthorship W4367693876A5076431340 @default.
• W4367693876 hasAuthorship W4367693876A5079051079 @default.
• W4367693876 hasAuthorship W4367693876A5080954307 @default.
• W4367693876 hasAuthorship W4367693876A5081922663 @default.
• W4367693876 hasAuthorship W4367693876A5089723266 @default.
• W4367693876 hasAuthorship W4367693876A5091086764 @default.
• W4367693876 hasBestOaLocation W43676938761 @default.
• W4367693876 hasConcept C126322002 @default.
• W4367693876 hasConcept C156957248 @default.
• W4367693876 hasConcept C159110408 @default.
• W4367693876 hasConcept C170493617 @default.
• W4367693876 hasConcept C194828623 @default.
• W4367693876 hasConcept C2776135927 @default.
• W4367693876 hasConcept C2777512617 @default.
• W4367693876 hasConcept C2778750930 @default.
• W4367693876 hasConcept C2778949969 @default.
• W4367693876 hasConcept C2779418921 @default.
• W4367693876 hasConcept C2780724011 @default.
• W4367693876 hasConcept C2781063702 @default.

• next